Skip to main content
OpenTrials

Clinical trial condition

Chronic Hepatitis C

Explore clinical trials studying Chronic Hepatitis C. Study availability and eligibility vary by location and protocol.

278 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Chronic Hepatitis C trial results

Completed

Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)

NCT01604850

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • SCTI Research Foundation Coronado, California, United States
  • Kaiser Permanente Los Angeles, California, United States
  • Peter J. Ruane, MD, Inc. Los Angeles, California, United States
  • Anthony Mills MD, Inc. Los Angeles, California, United States
View all 67 locations
View Trial Details
Completed

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon

NCT01542788

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • SCTI Research Foundation Liver Center Coronado, California, United States
  • Kaiser Permanente Los Angeles, California, United States
  • Lightspeed Medical Los Angeles, California, United States
View all 63 locations
View Trial Details
Completed

Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection

NCT01641640

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • SCTI Research Foundation Coronado, California, United States
  • Kaiser Permanente Los Angeles, California, United States
  • Peter J. Ruane, MD, Inc. Los Angeles, California, United States
View all 56 locations
View Trial Details
Completed

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C

NCT00495391

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • VA Palo Alto Healthcare System Palo Alto, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • Yale University Digestive Diseases New Haven, Connecticut, United States
  • University of Florida Hepatology Gainesville, Florida, United States
View Trial Details
Completed

Virological Response Study of the HCV Vaccine IC41

NCT00601770

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Prof. Dr. Ulrich Spengler Bonn, Germany
  • Prof. Dr. Michael Manns Hanover, Hannover, Germany
  • Dr. Granzyna Cholewinska-Szymanska Warzawa, Poland
  • Prof. Dr. Andrzej Gladszy Wroclaw, Poland
View Trial Details
Completed

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients

NCT00637923

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Palo Alto VA Healthcare System Palo Alto, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Bay Pines VA Healthcare System Bay Pines, Florida, United States
  • Florida Center for Gastroenterology Largo, Florida, United States
View Trial Details

Related conditions